Moffitt Cancer Center says Humana, not the hospital, terminated their Medicare Advantage agreement. The center has been out of network for Humana Medicare Advantage HMO and PPO members since July 1, 2026. For patients in active cancer treatment, the immediate financial question is whether continuity protection preserves in-network coverage long enough to complete a course of care.
The official notice identifies who ended the agreement
Moffitt’s current insurance announcement says Humana terminated the contract after negotiations. The center states that it did not choose to leave the network and that ordinary Humana Medicare Advantage coverage changed July 1.
The distinction matters because patients may receive conflicting explanations from the plan, broker and provider. The written notice establishes Moffitt’s position, but the Humana plan controls each member’s benefits, authorizations and cost sharing. A patient should obtain the plan’s determination for the exact physician, facility and treatment.
Cancer care can produce separate professional, infusion, imaging, laboratory and hospital claims. Confirmation for an oncology visit does not automatically settle every related service. Each authorization should identify the covered provider, service and time period.
Free retirement updates: Social Security and Medicare change every year, and nobody sends you a memo. Our free Retirement Shield newsletter breaks down what changed and what to do. Get it free in your inbox.
Continuity coverage needs written boundaries
Federal and state protections may allow some patients already receiving treatment to continue temporarily at in-network rates. That protection can depend on clinical status, the start of treatment and a plan-approved transition period. It should never be assumed from an appointment remaining on the calendar.
A written approval should state the end date, authorized providers, services and cost-sharing level. The plan’s reference number and representative name belong with treatment records. If a claim later processes as out of network, that evidence supports an appeal.
Patients denied continuity treatment can use the appeal process described in Medicare’s rights and protections guide. An expedited decision may be available when delay could seriously harm health.
The retirement cost extends beyond one copay
Out-of-network cancer care can add higher coinsurance, a separate deductible or uncovered HMO charges. Travel to a replacement center, repeated diagnostic work and time away from a caregiver’s job can magnify the direct medical bill.
A financial comparison should include the full treatment pathway, not just the next office visit. The plan should identify an in-network oncologist and facility capable of continuing the regimen if Moffitt coverage cannot be preserved. Medical records should be transferred before the transition date.
Changing Medicare Advantage plans may be possible only during a valid enrollment period or special enrollment opportunity. A network dispute by itself does not create unlimited freedom to switch, so Medicare or SHIP counseling can clarify current options without relying on a sales pitch.
The source-led conclusion is about present access
A medication administered at the cancer center deserves a separate coverage check from a drug picked up at a pharmacy. Part B may cover clinician-administered drugs, while Part D covers many retail prescriptions. Moving treatment can therefore change both the provider network and the drug benefit involved.
Clinical records should include pathology, imaging, treatment plans and recent laboratory results before a transfer. Repeating those services can add cost and delay. The receiving team should confirm which records are adequate and whether new baseline testing is medically necessary.
Transportation and caregiver availability belong in the comparison. A nominally in-network center that requires a much longer trip may add fuel, lodging or paid help. Those costs are not shown in the plan’s maximum out-of-pocket figure but still come from retirement income.
Billing errors should be challenged first through the plan’s explanation of benefits. The reason code distinguishes a network problem from missing authorization, coding or medical-necessity issues. Appealing the wrong issue can waste a limited response period.
Moffitt’s page does not describe a future possibility. It says the Humana agreement ended and the center is out of network as of July 1, while placing responsibility for termination on Humana. That current status should drive every coverage conversation.
The protective sequence is practical: secure a written continuity decision, map every biller in the treatment plan, calculate the full out-of-network exposure and preserve appeal deadlines. The agency question is settled by Moffitt’s notice; the member’s documents settle the dollars.
A patient who pays a disputed bill should keep proof and avoid signing away appeal rights. Reimbursement may depend on timely submission of the itemized statement and plan denial. Hospital payment plans can manage cash flow, but they do not convert an out-of-network charge into an approved benefit or resolve the underlying coverage dispute.
This article was created with AI assistance and was reviewed, edited, and fact-checked by The Financial Wire editorial team.
More Financial Reading
- The ideal retirement withdrawal rate so your savings actually last
- Bank statements: how long to keep them and when to toss them
Warren Cohen is a finance writer based in Phoenix, Arizona, covering personal finance topics including credit, banking, and beginner investing. He earned his degree in business administration from Arizona State University and began his career working in consumer finance, where he gained direct experience with lending and credit systems. He now writes for personal finance websites and fintech platforms, focusing on clear, practical content that helps readers make informed financial decisions.
